Thus, inhibiting DPP4 activity is an effective strategy for reducing blood glucose levels by preventing the breakdown of plasma GLP-1 for the treatment of type 2 diabetes mellitus (T2DM) [11]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.